Human Molecular Genetics, 2002, Vol. 11, No. 19 2233-2241
© 2002 Oxford University Press
Identification of a presymptomatic molecular phenotype in Hdh CAG knock-in mice
Molecular Neurogenetics Unit, Massachusetts General Hospital, Building 149, 13th Street, Charlestown, MA 02129, USA
Received April 10, 2002; Accepted July 18, 2002
The hallmark striatal neurodegeneration of Huntington's disease (HD) is first triggered by a dominant property of the expanded glutamine tract in mutant huntingtin that increases in severity with glutamine size. Indeed 111-glutamine murine huntingtin leads to a dominant cascade of phenotypes in HdhQ111 mice, although these abnormalities are not manifest in HdhQ50 mice, with 50-glutamine mutant protein. Therefore, to identify phenotypes that might reflect events closer to the fundamental trigger mechanism, and that can be measured as a consequence of adult-onset HD mutant huntingtin, we have screened for altered expression of genes conserved in evolution, which are likely to encode essential proteins. Probes generated from HdhQ111 homozygote and wild-type striatal RNAs were hybridized to human gene segments on filter arrays, disclosing a mutant-specific increase in hybridization to Rrs1, encoding a ribosomal protein. Subsequent, quantitative RTPCR assays demonstrated increased Rrs1 mRNA from 3 weeks of age in homozygous and heterozygous HdhQ111 striatum and increased Rrs1 mRNA expression with a single copy's worth of 50-glutamine mutant huntingtin in HdhQ50 striatum. Moreover, quantitative RTPCR assays for the human homologue demonstrated elevated Rrs1 mRNA in HD compared with control postmortem brain. These findings, therefore, support a chronic impact of mutant huntingtin on an essential ribosomal regulatory gene to be investigated for its role very early in HD pathogenesis.
* To whom correspondence should be addressed. Tel: +1 6177265726; Fax: +1 6177265736; Email: persiche{at}helix.mgh.harvard.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Kuhn, D. R. Goldstein, A. Hodges, A. D. Strand, T. Sengstag, C. Kooperberg, K. Becanovic, M. A. Pouladi, K. Sathasivam, J.-H. J. Cha, et al. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage Hum. Mol. Genet., August 1, 2007; 16(15): 1845 - 1861. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lloret, E. Dragileva, A. Teed, J. Espinola, E. Fossale, T. Gillis, E. Lopez, R. H. Myers, M. E. MacDonald, and V. C. Wheeler Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice Hum. Mol. Genet., June 15, 2006; 15(12): 2015 - 2024. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nariai, T. Tanaka, T. Okada, C. Shirai, C. Horigome, and K. Mizuta Synergistic defect in 60S ribosomal subunit assembly caused by a mutation of Rrs1p, a ribosomal protein L11-binding protein, and 3'-extension of 5S rRNA in Saccharomyces cerevisiae Nucleic Acids Res., August 12, 2005; 33(14): 4553 - 4562. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Everett and N. W. Wood Trinucleotide repeats and neurodegenerative disease Brain, November 1, 2004; 127(11): 2385 - 2405. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gines, E. Ivanova, I.-S. Seong, C. A. Saura, and M. E. MacDonald Enhanced Akt Signaling Is an Early Pro-survival Response That Reflects N-Methyl-D-aspartate Receptor Activation in Huntington's Disease Knock-in Striatal Cells J. Biol. Chem., December 12, 2003; 278(50): 50514 - 50522. [Abstract] [Full Text] [PDF] |
||||



